ArticleBMC urology2021

A novel germline BRCA2 mutation in a Chinese patient with prostate cancer sensitive to platinum chemotherapy: a case report.

Lijuan Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.